FDA Selects Premier Healthcare Alliance As Source For Inpatient Drug Data

The U.S. Food and Drug Administration (FDA) has awarded a multi-year contract to the Premier healthcare alliance to provide data for post-marketing drug surveillance, supporting the FDA’s Office of Surveillance and Epidemiology and the Office of New Drugs, Pediatric and Maternal Health staff in their effort to evaluate drug risks and promote the safer use of prescription drugs by Americans. The FDA has accessed Perspective information relating to inpatient drug use in hospitals since 2001. [click link for full article]

More: continued here

Filed under: Public Health on November 11th, 2007